Quarterly report · Q2
4323.TEDINET S100PJPL
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥21.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.0bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥1.0bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥992m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.0bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.0bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.0bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥738m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥687m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥748m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥692m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥15.7bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥15.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥14.2bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥6.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥9.9bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥9.2bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.6bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.0bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.0bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.3bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥819m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥839m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥86m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥81m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥57m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥273m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥487m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥593m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥60.16 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.91 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥112.32 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.22 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.16 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 62.5% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.6% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥89m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥89m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥852m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥19m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥184m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥719m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥719m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥71m |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥28m |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥556m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥11.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥11.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥89m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥1.9bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥33m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥33m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥764m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥906m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥897m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥8m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥203,000 |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥740m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥740m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥131m |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2m |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥786m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥10.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥10.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥33m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 547
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes and accounts payable trade | Prior1YearInstant | 1380056000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 1085624000 | JPY |
| Short term loans payable | Prior1YearInstant | 8518000 | JPY |
| Short term loans payable | CurrentQuarterInstant | - | JPY |
| Income taxes payable | Prior1YearInstant | 563468000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 183911000 | JPY |
| Contract liabilities | Prior1YearInstant | 430851000 | JPY |
| Contract liabilities | CurrentQuarterInstant | 1154613000 | JPY |
| Provision for bonuses | Prior1YearInstant | 1194536000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 867638000 | JPY |
| Provision for directors bonuses | Prior1YearInstant | 77530000 | JPY |
| Provision for directors bonuses | CurrentQuarterInstant | 32940000 | JPY |
| Provision for loss on construction contracts | Prior1YearInstant | 52960000 | JPY |
| Provision for loss on construction contracts | CurrentQuarterInstant | 63104000 | JPY |
| Other cl | Prior1YearInstant | 913152000 | JPY |
| Other cl | CurrentQuarterInstant | 680670000 | JPY |
| Current liabilities | Prior1YearInstant | 4621074000 | JPY |
| Current liabilities | CurrentQuarterInstant | 4068504000 | JPY |
| Provision for share based remuneration for directors and other officers ncl | Prior1YearInstant | 120728000 | JPY |
| Provision for share based remuneration for directors and other officers ncl | CurrentQuarterInstant | 132636000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 6646000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | - | JPY |
| Net defined benefit liability | Prior1YearInstant | 1058791000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 1070323000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 24655000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 40159000 | JPY |
| Other ncl | Prior1YearInstant | 513608000 | JPY |
| Other ncl | CurrentQuarterInstant | 522748000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 1724430000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 1765867000 | JPY |
| Liabilities | Prior1YearInstant | 6345505000 | JPY |
| Liabilities | CurrentQuarterInstant | 5834371000 | JPY |
| Capital stock | Prior1YearInstant | 1535409000 | JPY |
| Capital stock | CurrentQuarterInstant | 1535409000 | JPY |
| Capital surplus | Prior1YearInstant | 1703991000 | JPY |
| Capital surplus | CurrentQuarterInstant | 1702732000 | JPY |
| Retained earnings | Prior1YearInstant | 5865484000 | JPY |
| Retained earnings | CurrentQuarterInstant | 6355035000 | JPY |
| Treasury stock | Prior1YearInstant | -175264000 | JPY |
| Treasury stock | CurrentQuarterInstant | -175649000 | JPY |
| Shareholders equity | Prior1YearInstant | 8929621000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 9417527000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 121768000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 122494000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -2240000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 161728000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 110706000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 101882000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 230234000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 386105000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |